0000899243-20-030508.txt : 20201105
0000899243-20-030508.hdr.sgml : 20201105
20201105210840
ACCESSION NUMBER: 0000899243-20-030508
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201103
FILED AS OF DATE: 20201105
DATE AS OF CHANGE: 20201105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GUY GEOFFREY W DR
CENTRAL INDEX KEY: 0000941388
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35892
FILM NUMBER: 201292205
MAIL ADDRESS:
STREET 1: ETHICAL HOLDINGS PLC CORPUS CHRISTI
STREET 2: HOUSE 9 WEST STREET GODMANCHESTER
CITY: CAMBRIDGESHIRE PE18
STATE: A1
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GW PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001351288
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SOVEREIGN HOUSE
STREET 2: VISION PARK
CITY: HISTON, CAMBRIDGE CB24 9BZ
STATE: X0
ZIP: 00000
BUSINESS PHONE: 44 1223 266800
MAIL ADDRESS:
STREET 1: SOVEREIGN HOUSE
STREET 2: VISION PARK
CITY: HISTON, CAMBRIDGE CB24 9BZ
STATE: X0
ZIP: 00000
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-03
0
0001351288
GW PHARMACEUTICALS PLC
GWPH
0000941388
GUY GEOFFREY W DR
SOVEREIGN HOUSE, VISION PARK, HISTON
CAMBRIDGE
X0
CB24 9BZ
UNITED KINGDOM
1
1
0
0
Executive Chairman
Ordinary Shares
2020-11-03
4
M
0
9732
0.0013
A
5511253
D
Ordinary Shares
2020-11-03
4
M
0
25913
0.0013
A
5537166
D
Ordinary Shares
2020-11-03
4
M
0
15336
0.0013
A
5552502
D
Ordinary Shares
2020-11-03
4
M
0
15336
0.0013
A
5567838
D
Ordinary Shares
2020-11-03
4
M
0
204552
0.0013
A
5772390
D
Ordinary Shares
2020-11-03
4
M
0
9262
0.0013
A
5781652
D
Ordinary Shares
2020-11-03
4
M
0
16317
0.0013
A
5797969
D
Ordinary Shares
2020-11-03
4
M
0
10704
0.0013
A
5808673
D
Ordinary Shares
2020-11-03
4
S
0
56388
8.37
D
5752285
D
Ordinary Shares
2020-11-03
4
S
0
140040
8.48
D
5612245
D
Ordinary Shares
2020-11-03
4
S
0
92724
8.54
D
5519521
D
Ordinary Shares
2020-11-03
4
S
0
18000
8.59
D
5501521
D
Stock Options
0.0013
2020-11-03
4
M
0
9740.25
0.00
D
2019-06-24
2025-06-24
Ordinary Shares
9732
8
D
Stock Options
0.0013
2020-11-03
4
M
0
25913
0.00
D
2020-02-15
2026-02-15
Ordinary Shares
25913
0
D
Stock Options
0.0013
2020-11-03
4
M
0
15336
0.00
D
2019-08-10
2027-08-10
Ordinary Shares
15336
0
D
Stock Options
0.0013
2020-11-03
4
M
0
15336
0.00
D
2020-08-10
2027-08-10
Ordinary Shares
15336
0
D
Stock Options
0.0013
2020-11-03
4
M
0
204552
0.00
D
2020-08-10
2027-08-10
Ordinary Shares
204552
0
D
Stock Options
0.0013
2020-11-03
4
M
0
9262
0.00
D
2019-02-26
2028-02-26
Ordinary Shares
9262
0
D
Stock Options
0.0013
2020-11-03
4
M
0
16317
0.00
D
2020-02-26
2028-02-26
Ordinary Shares
16317
0
D
Stock Options
0.0013
2020-11-03
4
M
0
10704
0.00
D
2020-03-01
2029-03-01
Ordinary Shares
10704
0
D
Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.31 U.S. Dollars as of November 3, 2020.
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 18, 2020.
Represented by ADS.
The price reported in Column 4 is a weighted average price per ordinary share ($100.49 per ADS). These shares were sold in multiple transactions at prices ranging from $100.00 per ADS (or $8.33 per ordinary share) to $100.98 per ADS (or $8.42 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price per ordinary share ($101.81 per ADS). These shares were sold in multiple transactions at prices ranging from $101.00 per ADS (or $8.42 per ordinary share) to $101.99 per ADS (or $8.50 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price per ordinary share ($102.45 per ADS). These shares were sold in multiple transactions at prices ranging from $102.00 per ADS (or $9.50 per ordinary share) to $102.99 per ADS (or $8.58 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price per ordinary share ($103.08 per ADS). These shares were sold in multiple transactions at prices ranging from $103.08 per ADS (or $8.59 per ordinary share) to $103.09 per ADS (or $8.59 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Geoffrey W. Guy
2020-11-05